COMPLEX MOLECULAR MECHANISM FOR DIHYDROPYRIDINE BINDING TO L-TYPE CA2+-CHANNELS AS REVEALED BY FLUORESCENCE RESONANCE ENERGY-TRANSFER

被引:30
作者
BERGER, W [1 ]
PRINZ, H [1 ]
STRIESSNIG, J [1 ]
KANG, HC [1 ]
HAUGLAND, R [1 ]
GLOSSMANN, H [1 ]
机构
[1] UNIV INNSBRUCK, INST BIOCHEM PHARMAKOL, A-6020 INNSBRUCK, AUSTRIA
关键词
D O I
10.1021/bi00205a025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analyzed binding-induced changes in the fluorescence properties of the 1,4-dihydropyridine (DHP), DMBODIPY-DHP [(-)-1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic acid 2-[4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-3-(s-indacene)propionylamino]ethylethyl ester)], to study the molecular mechanisms underlying the interaction of DHPs with the alpha(1)-subunit of skeletal muscle L-type Ca2+ channels. The quantum yield of the fluorophore DMBODIPY was similar in solvents of different polarity. In contrast, the quantum yield of DMBODIPY-DHP was low in buffer but increased with solvent polarity and upon specific binding. This indicates the existence of binding-induced changes of intramolecular quenching of the fluorophore by the DHP moiety. Specific ligand binding also induced fluorescence resonance energy transfer (FRET) between one or more tryptophanes of the channel protein and the DMBODIPY-DHP fluorophore. The specific FRET signal was successfully used to directly measure DHP binding at high time resolution. It revealed complex association and dissociation kinetics of DMBODIPY-DHP although no site heterogeneity was detected in equilibrium experiments. We therefore fitted our data to a binding scheme considering one or more intermediate conformational states for the formation of the ligand-receptor complex. Such a step-wise binding mechanism explains previously observed differences in the binding site densities and the kinetic constants determined for different DHPs using conventional binding (for example filtration) assays.
引用
收藏
页码:11875 / 11883
页数:9
相关论文
共 20 条
[1]   CLASSES OF CALCIUM CHANNELS IN VERTEBRATE CELLS [J].
BEAN, BP .
ANNUAL REVIEW OF PHYSIOLOGY, 1989, 51 :367-384
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   RECEPTOR-SITES FOR CA2+ CHANNEL ANTAGONISTS [J].
CATTERALL, WA ;
STRIESSNIG, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (06) :256-262
[4]   SIMULTANEOUS ANALYSIS OF FAMILIES OF SIGMOIDAL CURVES - APPLICATION TO BIOASSAY, RADIOLIGAND ASSAY, AND PHYSIOLOGICAL DOSE-RESPONSE CURVES [J].
DELEAN, A ;
MUNSON, PJ ;
RODBARD, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 235 (02) :E97-E102
[5]  
GLOSSMANN H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1917
[6]  
GLOSSMANN H, 1985, METHOD ENZYMOL, V109, P513
[7]  
GLOSSMANN H, 1990, REV PHYSL BIOCH PHAR, V114, P1
[8]   INVIVO LABELING OF L-TYPE CA(2+) CHANNELS BY FLUORESCENT DIHYDROPYRIDINES - EVIDENCE FOR A FUNCTIONAL, EXTRACELLULAR HEPARIN-BINDING SITE [J].
KNAUS, HG ;
MOSHAMMER, T ;
FRIEDRICH, K ;
KANG, HC ;
HAUGLAND, RP ;
GLOSSMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3586-3590
[9]  
KNAUS HG, 1992, J BIOL CHEM, V267, P2179
[10]  
KNAUS HG, 1992, MOL PHARMACOL, V41, P298